Retrospective analysis shows rising antimicrobial resistance in Campylobacter gastroenteritis, suggesting urgent surveillance needed.
Antimicrobial resistance in Campylobacter is a global concern. We conducted a single‐centre retrospective observational study to investigate antimicrobial resistance in adult patients with Campylobacter gastroenteritis (2020–2023). From our cohort of 331 patients over 3 years, there was 22% ciprofloxacin resistance and 100% susceptibility to erythromycin. Compared to prior literature in Australia, ciprofloxacin resistance has increased over time. Ongoing antimicrobial surveillance, stewardship and review of treatment guidelines are recommended.
No takes yet. Share an insight, caveat, or question.
Yerramilli et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: